Kennedy Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Kennedy Capital Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-49,065	Closed	-$7.27M	–	763
2014 Q4	$7.27M	Sell	49,065 -40,073	-45%	-$5.89M	0.13%	283
2014 Q3	$13.7M	Sell	89,138 -11,573	-11%	-$1.74M	0.27%	92
2014 Q2	$14.1M	Buy	100,711 +639	+0.6%	+$70.9K	0.26%	111
2014 Q1	$11.1M	Buy	100,072 +2,343	+2%	+$255K	0.21%	166
2013 Q4	$9.66M	Buy	97,729 +20,146	+26%	+$1.75M	0.18%	206
2013 Q3	$5.9M	Buy	+77,583	New	+$5.03M	0.11%	337

Other funds holding TARO

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GCM

Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return

AIM

Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return

Kennedy Capital Management's TARO Position: Q1 2015 in Review

Kennedy Capital Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2015, closing a stake of 49,065 shares — an estimated $7.27M sold.

Kennedy Capital Management first reported a position in TARO in Q3 2013 and held it in 6 quarters. The position peaked at $14.1M in Q2 2014. 96 funds tracked by Wall St. Rank hold TARO as of Q1 2015.

Kennedy Capital Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2015 after selling out during the quarter.
Kennedy Capital Management sold 49,065 Taro Pharmaceutical Industries Ltd. shares in Q1 2015, an estimated $7.27M.
Kennedy Capital Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2013 and held it in 6 quarters.
Kennedy Capital Management's Taro Pharmaceutical Industries Ltd. position peaked at $14.1M in Q2 2014.
96 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2015.

Based on Kennedy Capital Management's 13F filing for Q1 2015, filed 7 May 2015.